Modified observe‐and‐plan regimen using aflibercept for neovascular age‐related macular degeneration

Several treatment strategies with anti-vascular endothelial growth factor are available for patients with neovascular age-related macular degeneration (nAMD). The treat-and-extend (TAE) regimen reduces the burden of injections, compared to a monthly dosing regimen (Abedi et al. 2014). However, the possibility of over-treatment is inherent in patients with little or no recurrence. The regularity of the retreatment rhythm in nAMD has already been...